Within the extensive array of molecular contributors, the AP-2 family has emerged as a pivotal regulator in CRC, with AP-2α, AP-2γ, and AP-2ε manifesting critical and well-described regulatory roles. Here, TFAP2A is linked to colorectal carcinoma.